LegislationPatent Reform Vision by Dan Leckrone
America has no greater asset than the ideas generated through hard work and imagination. These ideas have long been protected by Patents, which have played a vital role in America's economic expansion and prosperity. With Patents playing such a principal role in the economic success of the past, it is shocking that the United States Congress, the very body that is meant to represent the interest of the overall good, has decided to pursue a policy that would weaken control of America's ideas and make vulnerable the American economy. This policy is being enacted through the "Patent Reform Act", which has the goal of watering down Patents in order to protect big business from lawsuits -- lawsuits which require payment for the use of the technology appropriated. While the bill's authors may have sincere intentions, if enacted this law would do a great disservice to the American entrepreneurs. It will drastically weaken the Patent System, making it harder for inventors to protect the ideas they worked to create. The irony behind this legislation is that many of the "Patent Reform Act" prime supporters are businesses that have risen to the top of the industry using the very same Patents they now wish to deteriorate. It is unfortunate that these Companies do not wish to bestow the same opportunities to others that they themselves have received. At The TPL Group we feel that all businesses, whether public or private, big or small, deserve the opportunity to develop and protect their own ideas. With the goal of economic equality in mind we join with a growing number of businesses, universities and others who feel that the Patent Reform Act should not weaken the ability of Americans to protect their ideas. Organizations who have Publicly Expressed Concerns about the Proposed Patent Legislation 
Abbott Laboratories ♦ AdaMed (Advanced Medical Technology Association) ♦ AFL CIO (American Federation of Labor and Congress of Industrial Organizations) ♦ AmberWave Systems ♦ Air Liquide America ♦ Astra-Zeneca ♦ Aware, Inc. ♦ Baxter Healthcare ♦ Beckman Coulter ♦ Bio.org ♦ Boston Scientific ♦ Bridgestone (Americas) ♦ Bristol-Myers Squibb ♦ Canopy Venture Partners, LLC ♦ Cantor Fitzgerald, LP ♦ Cargill ♦ Caterpillar Inc. ♦ Cephalon ♦ CheckFree ♦ Cornell University ♦ Corning ♦ Cryptography Research ♦ Dartmouth Regional Technology Center ♦ Dow Chemical ♦ Eastman Chemical ♦ EFI (Electronics for Imaging) ♦ E.I. duPont(DuPont) ♦ Eli Lilly ♦ Enterprise Partners Venture Capital ♦ ExxonMobil ♦ Fallbrook Technologies, Inc. ♦ General Electric ♦ Helius, Inc. ♦ Genzyme ♦ GlaxoSmithKline ♦ Henkel ♦ Immersion Corporation ♦ Hoffman-LaRoche ♦ IEEE - USA (The Insitute of Electrical and Electronics Engineers, Inc. ♦ IFPTE - International Federation of Professional & Technical Engineers ♦ Innovation Alliance ♦ InterDigital Communications Corporation ♦ Intermolecular, Inc. ♦ Johnson & Johnson ♦ LSI ♦ MDMA - Medical Device Manufcuturers Asscociation ♦ Medtronic ♦ Merck ♦ Millennium ♦ Mohr, Davidow Ventures ♦ Monsanto ♦ Motorola ♦ Nanosys, Inc. ♦ National Venture Capitalist Association ♦ Neoconix, Inc. ♦ North Dakota State University ♦ Novartis ♦ Pfizer ♦ Procter & Gamble ♦ QUALCOMM, Inc. ♦ SanDisk Corporation ♦ Sangamo BioSciences ♦ State of New Hampshire Department of Resources and Economics ♦ StemCells ♦ Symyx ♦ Tessera ♦ Texas Instruments ♦ 3M Company ♦ 21st Century Coalition ♦ United Technologies ♦ USW - United Steelworkers ♦ University of California ♦ University of Maryland ♦ University of New Hampshire ♦ University of North Carolina System ♦ University of Utah ♦ University of Wisconsin-Madison ♦ Vanderbilt Unversity and Medical Center ♦ Venture Investors LLC ♦ Weyerhaeuser ♦ Wilson Sonsini Goodrich & Rosati ♦ Wyeth |
January 07, 2009NEWS ALERTSTPL GROUP Dec 22, 2008 Sep 24, 2008 PATENT REFORM Dec 5, 2008 Sep 28, 2008 CALL TO ACTIONWrite your Senator or Business Associates opposing the current patent reform bill in the Senate.
|
© 2005-2007 Technology Properties Limited (TPL)